LipoCoat

LipoCoat is a pioneering Dutch biotech company known for its 'bio-inspired coatings' that enhance medical device safety and counteract antibiotic resistance. Established in 2016, this innovative company focuses on creating sustainable infection control solutions. Their technology, which garners merits such as anti-fouling properties for proteins and bacteria, hydrophilic and lubricious qualities, and self-healing features, positions them as a leader in the biotech sector.

LipoCoat operates from the Netherlands and is heavily involved in both medical devices and drug discovery, seeking to improve public health through novel surface solutions. Their patent-based technology is characterized by its versatility, applicable to diverse biomaterials, and thickness of just 5 nanometers.

The company has been recognized with over 20 accolades, underscoring its innovation and market potential. Among its accolades are the titles of 'European Biotech Startup of 2019' and 'Best Medical Device Coatings Company of 2020'. Following a €1.50M Series A investment in April 2020, with funding from Lumana Invest, High Tech Fund, and Rabobank Delft Innovation Fund, LipoCoat is well-positioned for continued growth in the Biotechnology, Health Care, and Medical Devices industries.